← Evidence map

ArticlePloS one2015

Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients. | OpenQuestion